Amgen's fast-growing cancer immunotherapy Imdelltra could move into the first-line setting in small cell lung cancer (SCLC), ...
The pivotal QUINTESSENTIAL trial of the potentially first-in-class CAR-T showed a "statistically significant and clinically ...
Every few years, drug development goes through a moment where a new technology promises to change everything. Artificial ...
The FDA has started a priority review of AstraZeneca's IL-33-targeting antibody tozorakimab for chronic obstructive pulmonary ...
An AI-powered imaging tool developed by Brainomix has been used to enrich data from a phase 2a trial of Endeavor BioMedicines ...
Registration and the full programme are available on the DIA-MHRA Global Summit page. Follow the conversation at ...
Different regions have distinct healthcare systems, varying access levels, reimbursement models, and treatment realities — ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results